Epstein-Barr virus infection of T cells: Implications for altered T-lymphocyte activation, repertoire development and autoimmunity

Immunological Reviews

Volumn , Issue 152, 1996, Pages 89-110

  Dreyfus, David H ^a   Kelleher, Colm A ^a   Jones, James F ^a   Gelfand, Erwin W ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN;

AUTOIMMUNITY; B LYMPHOCYTE; EPSTEIN BARR VIRUS; ETIOLOGY; GENE LOCUS; GENETIC RECOMBINATION; GENETIC TRANSCRIPTION; HUMAN; IMMUNOMODULATION; LATENT VIRUS INFECTION; LYMPHOPROLIFERATIVE DISEASE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; RNA ANALYSIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TANDEM REPEAT; THYMOCYTE; VIRUS INFECTION; VIRUS RECOMBINATION; VIRUS REPLICATION; AMINO ACID SEQUENCE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOLECULAR GENETICS; SIGNAL TRANSDUCTION; VIROLOGY;

AMINO ACID SEQUENCE; AUTOIMMUNITY; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULINS; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; RECOMBINATION, GENETIC; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0029658202     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065x.1996.tb00912.x     Document Type: Review

References (67)

1. Alfieri, C., Birkenbach, M. & Kieff, E. (1991) Early events in Epstein-Barr virus infection of human B lymphocytes. Virology 181, 595.
2. Anagnostopoulos, I., Hummel, M., Finn, T., Tiemann, M., Korbjuhn, P., Dimmler, C., Gatter, K., Dallenbach, F., Parwaresch, M. R. & Stein, H. (1992) Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood 80, 1804.
3. Anagnostopolous, I., Hummel, M., Kreschel, C. & Stein, H. (1995) Morphology, immunophenotype and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. Blood 85, 744.
4. Baer, R., Bankier, A. T., Biggin, M. D., Deininger, P. L., Farrell, P. J., Gibson, T. J., Hatfull, G., Hudson, G. S., Satchwell, S. C., Seguin, C., Tuffnell, P. S. & Barrell, B. G. (1984) DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310, 207.
5. deBruyn-Kops, A. & Knipe, D. M. (1988) Formation of DNA replication structures in herpes virus-infected cells requires a viral DNA binding protein. Cell 55, 857.
6. Chen, C. L., Sadler, R. H., Walling, D. M., Su, I. J., Hsieh, H.C. & Raab-Traub, N. (1993) Epstein-Barr Virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas. J. Virol. 67, 6303.
7. Countryman, J., Jensen, H., Siebl, R., Wolf, H. & Miller, G. (1987) Polymorphic proteins encoded within BZLF-1 of defective and standard Epstein-Barr viruses disrupt latency. J. Virol. 61, 3672.
8. Cuomo, C. A. & Oettinger, M. A. (1994) Analysis of regions of RAG-2 important for V(D)J recombination. Nucl. Acids Rsch. 22, 1810.
9. Decaussin, G., Leclerc, V. & Ooka, T. (1995) The lytic cycle of Epstein-Barr virus in the non-producer Raji line can be rescued by the expression of a 135-kilodalton protein encoded by the BALF2 open reading frame. J. Virol. 69, 7309.
10. Doak, T. G., Doerder, F. P., Jahn, C. L. & Herrick, G. (1994) A proposed superfamily of transposase genes: transposon-like elements in ciliated protozoa and a common 'D35E' motif. Proc. Natl. Acad. Sci. USA 91, 942.
11. Dreyfus, D. H. (1992) Evidence suggesting an evolutionary relationship between transposable elements and immune system recombination sequences. Molec. Immunol. 29, 807.
12. Dyda, F., Hickman, A.B., Jenkins, T.M., Engelman, A., Craigie, R. & Davies, D.R. (1994) Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases. Science 266, 1981.
13. Fingeroth, J. D., Clabby, M. L. & Strominger, J. D. (1988) Characterization of a T-lymphocyte Epstein-Barr virus/C3d receptor (CD21). J. Virol. 62, 1442.
14. Furnari, F. B., Zacny, V., Quinlivan, E. B., Kenney, S. & Pagano, J. (1994) RAZ, an Epstein-Barr virus transdominant repressor that modulates the viral reactivation mechanism. J. Virol. 68, 1827.
15. Giller, R. H. & Grosse, C. (1989) Epstein-Barr virus: the hematologic and oncologic consequences of virus-host interactions. Crit. Rev. Oncol. Hematol. 9, 149
16. Glickman, J. N., Howe, J. G. & Steitz, J. A. (1988) Structural analyses of EBER-1 and EBER-2 ribonucleoprotein particles present in Epstein-Barr virus infected cells. J. Virol. 62, 902.
17. Grindley, N.D.F. & Leschziner, A.E. (1995) DNA transposition: from a black box to a color monitor. Cell 83, 1063.
18. Gupte, S. S., Olson, J. W. & Ruyechan, W. T. (1991) The major herpes simplex virus type-1 DNA-binding protein is a zinc metalloprotein. J. Biol. Chem. 266, 11413.
19. Gustafsson, C. M., Falkenberg, M., Simonsson, S., Valadi, H. & Elias, P. (1995) The DNA ligands influence the interactions between the herpes simplex virus 1 origin binding protein and the single strand DNA-binding protein, ICP-8. J. Biol. Chem. 270, 19028.
20. Gutsch, D. E., Holley-Guthrie, E. A., Zhang, Q., Stein, B., Blanar, M. A., Baldwin, A. S. & Kenney, S. C. (1994) The BZIP transactivator of Epstein-Barr virus, BZLF1, functionally and physically interacts with the p65 subunit of NF-kappa B. Mol. Cell. Biol. 14, 1939.
21. Hesse, J. E., Lieber, M. R., Mizuuchi, K. & Gellert, M. (1989) V(D)J recombination: a functional definition of the joining signals. Genes Devel. 3, 1053.
22. Hitt, M. M., Allday, M. J., Hara, T., Karran, L., Jones, M. D., Busson, P., Tursz, T., Ernberg, I. & Griffin, B. E. (1989) EBV gene expression in an NPC-related tumour. EMBO J. 8, 2639.
23. Hurley, E. A. & Thorley-Lawson, D. A. (1979) B cell activation and the establishment of Epstein-Barr latency. J. Exp. Med. 168, 2059.
24. Jones, J. F., Shurin, S., Abramowsky, C., Tubbs, R. R., Sciotto, C. G., Wahl, R., Sands, J., Gottman, G., Katz, B. Z. & Sklar, J. (1988) T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr infections. New Eng. J. Med. 318, 733.
25. Jones, J. F., Wysocki, L. J., Streib, J. & Hull S. P. (1992) Possible use of the lymphocyte V gene recombinational system by EBV to achieve its own rearrangements. 5th Int. Symp. on Epstein-Barr Virus and Associated Diseases, Sept. 13-19, Annecy. France. Abstract book II, p. 121.
26. Kaufman-Patterson, R. L., Kelleher, C. A., Streib, J. E., Amankonah, T. D., Jones J. F. & Gelfand, E. W. (1995a) Activation of human thymocytes after infection with EBV. J. Immunol. 154, 1440.
27. Kaufman-Patterson, R. L., Kelleher, C., Amankonah, T. D., Streib, J.E., Xu, J.W., Jones, J. F. & Gelfand, E.W. (1995b) Model of EBV infection of human thymocytes: expression of viral genome and impact on cellular receptor expression in the T-lymphoblastic cell line, HPB-ALL. Blood 85, 456.
28. Kelleher, C., Kaufmann-Patterson, R., Dreyfus, D. H., Streib, J. E., Xu, J. W., Takase, K., Jones, J. F. & Gelfand, E. W. (1995) Epstein-Barr virus replicative gene transcription during de novo infection of human thymocytes: simultaneous early expression of BZLF-1 and its repressor RAZ. Virology 208, 685.
29. Kerr, B. M., Lear, A. L., Rowe, M., Croom-Carter, D., Young, L. S., Rookes, S. M., Gallimore, P. H. & Rickinson, A. B. (1992) Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: cell phenotype dependence of virus promoter usage. Virology 187, 189.
30. Khanna, R., Burrows, S. R. & Moss, D. J. (1995) Immune regulation in Epstein-Barr virus-associated diseases. Microbiol. Rev. 59, 387.
31. Kieff, E. & Liebowitz, D. (1990) Epstein-Barr virus and its replication. In: Virology, ed. B.N. Fields, p. 1889. Raven Press, New York.
32. Klein, G. (1994) Epstein-Barr virus strategy in normal and neoplastic B cells. Cell 77, 791.
33. Koizumi, S., Zhang X.-K., Imai, S., Sugiura, M., Usui, N. & Osato, T. (1992) Infection of the HTLV-1-harboring T-lymphoblastoid line MT-2 by Epstein-Barr virus. Virology 188, 859.
34. Kuhn-Hallek, I., Sage, D. R., Stein, L., Groelle, H. & Fingeroth, J. D. (1995) Expression of recombination activating genes (RAG-1 and RAG-2) in Epstein-Barr virus-bearing B cells. Blood 85, 1289.
35. Lear, A. L., Rowe, M., Kurilla, M. G., Lee, S., Henderson, S., Kieff, E. M. & Rickinson, A. B. (1992) The Epstein-Barr virus (EBV) nuclear antigen 1 BAMHIf promoter is activated on entry of EBV-transformed B cells into the lytic cycle. J. Virol. 66, 7461.
36. Leu, T. M. J. & Schatz, D.G. (1995) RAG1 and RAG2 are components of a high molecular-weight complex and association of RAG2 with this complex is RAG1 dependent. Mol. Cell. Biol. 15, 5657.
37. Lieberman, P. M., Hardwick, J. M., Sample, J., Hayward, G. S. & Hayward, S. D. (1990) The Zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virus-infected lymphocytes binds to both AP-1 and ZRE sites in target promoter and enhancer regions. J. Virol. 64, 1143.
38. Littler, E. J., Yeo, R. A., Killington, D. J., Purifoy, M. & Powell, K. L. (1981) Antigenic and structural conservation of herpes-virus DNA-binding proteins. J. Gen. Virol. 56, 409.
39. van Luenen, H. G. A. M., Colloms, S. D. & Plasterk, R. H. A. (1994) The mechanism of transposition of Tc3 in C. elegans. Cell 79, 293.
40. McBlane, J. F., van Gent, D. C., Ramsden, D. A., Romeo, C., Cuomo, C., Gellert, M. & Oettinger, M. (1995) Cleavage at a V(D)J recombination signal requires only RAG1 and RAG2 proteins and occurs in two steps. Cell 83, 387.
41. Manet, E., Gruffat, H., Trescol-Biemont, M. C., Moreno, N., Chambard, P., Giot, J. F. & Sergeant, A. (1989) Epstein-Barr virus bicistronic mRNAs generated by facultative splicing code for two transcriptional transactivalors. EMBO J. 8, 1819.
42. Marrack, P. & Kappler, J. (1990) The staphylococcal enterotoxins and their relatives. Science 24, 705.
43. Menetski, J. P. & Gellert, M. (1990) V(D)J recombination activity in lymphoid cell lines is increased by acents that elevate cAMP. Proc. Natl. Acad. Sci. USA 87, 9324.
44. Miller, G. (1990) Epstein-Barr Virus biology, pathogenesis and medical aspects. In: Virology (eds. B.N. Fields and D.M. Knipe), 2nd edn, p. 1921. Raven Press Ltd., NY.
45. Morikawa, S., Tatsumi, E., Baba, M., Harade, T. & Yasuhima, K. (1978) Two Erosette-forming lymphoid cell lines. Int. J. Cancer 21, 166.
46. Oettinger, M. A., Schatz, D. G., Gorka, C. & Baltimore, D. (1990) RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 248, 1517.
47. Plasterk, R. H. A. (1993) Molecular mechanisms of transposition and its control. Cell 74, 781.
48. Quinn, J. P. & McGeogh, D. J. (1985) DNA sequence of the region in the genome of the herpes simplex virus type 1 containing the genes for DNA polymerase and the major DNA binding protein. Nucl. Acids Res. 13, 8143.
49. Raab-Traub, N. & Flynn, K. (1986) The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47, 863.
50. Ruyechan, W. T. & Weir, A. C. (1984) Interaction with nucleic acids and stimulation of the viral DNA polymerase by the herpes simplex virus type 1 major DNA-binding protein. J. Virol. 52, 727.
51. Sadofsky, M. J., Hesse, J. E. & Gellert, M. (1994) Definition of a core region of RAG-2 that is functional in V(D)J recombination. Nucl. Acids Res. 22, 1805.
52. Schatz, D. G., Oettinger, M. A. & Baltimore, D. (1989) The V(D)J recombination activating gene, RAG-1. Cell 59, 1035.
53. Siegel, R. M., Katsumata, M., Komori, S., Wadsworth, S., Gill-Morse, L., Jerrold Jones, S., Bhandoola, A., Greene, M. I. & Yui, K. (1990) Mechanisms of autoimmunity in the context of T-cell tolerance: insights from natural and transgenic animal model systems. Immunol. Rev. 118, 165.
54. Silver, D. P., Spanopoulou, E., Mulligan, R. & Baltimore D. (1993) Dispensible sequence motifs in the RAG-1 and RAG-2 genes for plasmid V(D)J recombination. Proc. Natl. Acad. Sci. USA 90, 6100.
55. Slobod, K. S., Freiberg, A. S., Allan, J. E., Rencher, S. D. & Hurwitz, J. L. (1993) T cell receptor heterogeneity among Epstein-Barr virus-stimulated T-cell populations. Virology 196, 179.
56. Smith, T. J., Terada, N., Robinson, C. & Gelfand, E. W. (1993) Acute infectious mononucleosis stimulates the selective expression/expansion of V-β6.1-3 and V-β7 T Cells. Blood 81, 1521.
57. Spanopoulou, E., Cortes, P., Shih, C., Huang, C., Silver, D., Svec, P. & Baltimore, D. (1995) Localization, interaction and RNA binding properties of the V(D)J recombination-activating proteins RAG1 and RAG2. Immunity 3, 715.
58. Srinivas, S. & Sixbey, J. W. (1995) Epstein-Barr virus induction of recombinaseactivatina cenes RAG1 and RAG2. J. Virol. 69, 8155.
59. Su, I. J., Chen, R. L., Lin, D. T., Lin, K. S. & Chen, C. C. (1994) Epstein-Barr virus infects T-lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan. Am. J. Path. 144, 1219.
60. Sun, R., Spain, T. A., Lin, S. F. & Miller, G. (1994) Autoantigenic proteins that bind recombinogenic sequences in Epstein-Barr virus and cellular DNA. Proc. Natl. Acad. Sci. USA 91, 8646.
61. Thompson, C. B. (1995) New insights into V(D)J recombination and its role in the evolution of the immune system. Immunity 3, 531.
62. Tomkinson, B. E., Wagner, D. K., Nelson, D. L. & Sullivan, J. L. (1987) Activated lymphocytes during acute Epstein-Barr Virus infection. J. Immunol. 139, 3802.
63. Tsoukas, C. D. & Lambris, J. D. (1993) Expression of EBV/C3d receptors on T cells: Biological significance. Immunology Today 14, 56.
64. Turka, L. A., Schatz, D. G,. Oettinger, M. A., Chun, J. J. M., Gorka, C., Lee, K., McCormack, W. T. & Thompson C. B. (1991) Thymocyte expression of RAG-1 and RAG-2: termination by T cell receptor cross-linking. Science 253, 778.
65. Vaughan, J.H. (1995) The Epstein-Barr virus in autoimmunity. Spring. Sem. Immunopathol. 17, 203.
66. Watry, D., Hedrick, J. A., Siervo, S., Rhodes, G., Lamberti, J. J., Lambris, J. D. & Tsoukas, C. D. (1991) Infection of human thymocytes by Epstein-Barr virus. J. Exp. Med. 173, 971.
67. Yoshiyama, H., Shimizu, N. & Takada, K. (1995) Persistent Epstein-Barr virus infection in a human T-cell line: unique program of latent virus expression. EMBO J. 14, 3706.